Sai Parenteral’s IPO Sees Weak Demand on Day 1: Should Indian Investors Worry?
The initial public offering (IPO) of Sai Parenteral’s has received a lukewarm response from investors on Day 1, with the issue being subscribed only 0.05 times. What does this mean for Indian investors and the pharmaceutical sector?